Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Europace. 2011 Jun;13(6):780-8. doi: 10.1093/europace/euq435. Epub 2010 Dec 3.
Takotsubo cardiomyopathy (TC) or the apical ballooning syndrome is a reversible cardiomyopathy mimicking acute myocardial infarction (AMI). Although malignant arrhythmia is considered less likely to occur in TC than with AMI, sporadic reports of malignant arrhythmia with TC, however, have been reported. We reviewed the medical literature on TC and arrhythmias and describe in the summary the reported findings and discuss possible specific scenarios where arrhythmia may be more likely in patients with TC.
Articles were identified on PubMed using the MeSH terms 'Takotsubo Cardiomyopathy' or 'Apical Ballooning Syndrome'. Seventy-four unique case series with five or more TC patients were identified, with a cumulative total of 1876 cases. Twelve series (242 cases) were excluded because Mayo criteria were not met. Twenty-five series (816 cases, 43.5%) reported on arrhythmia and were included in the analysis.
Areas for further prospective study include the duration and mechanism of residual risk and optimal risk stratification and modification. The current state of evidence would support beta-blockers in the acute setting to control tachyarrhythmia, although there is little evidence to support their use beyond convalescence when used for this indication alone. Those in heart failure and cardiogenic shock should be managed with established evidence-based therapies for these conditions. The use of internal defibrillators in TC requires consideration only on a case-by-case basis.
心尖球囊样综合征(TC)或心尖气球样变综合征是一种类似于急性心肌梗死(AMI)的可逆转性心肌病。尽管恶性心律失常在 TC 中发生的可能性较 AMI 低,但也有 TC 伴恶性心律失常的散发病例报告。我们回顾了 TC 和心律失常的医学文献,并在摘要中描述了报告的发现,并讨论了心律失常在 TC 患者中更可能发生的可能特定情况。
使用 MeSH 术语“Takotsubo 心肌病”或“心尖球囊样综合征”在 PubMed 上搜索文章。确定了 74 个包含 5 例或 5 例以上 TC 患者的独特病例系列,共有 1876 例病例。12 个系列(242 例)因不符合 Mayo 标准而被排除在外。25 个系列(816 例,43.5%)报告了心律失常,并纳入分析。
进一步前瞻性研究的领域包括残留风险的持续时间和机制以及最佳风险分层和修正。目前的证据状况支持在急性期使用β受体阻滞剂来控制心动过速,尽管在单独用于该适应症的恢复期后,几乎没有证据支持其使用。那些患有心力衰竭和心源性休克的患者应按照这些病症的既定循证治疗方法进行管理。只有在个案基础上才需要考虑在 TC 中使用内置除颤器。